MiR-124-3p inhibits stomach adenocarcinoma progression by targeting AHR to induce autophagy

These findings establish miR-124-3p as a key suppressor of STAD progression via AHR-mediated autophagy, underscoring its promise as both a diagnostic biomarker and a therapeutic candidate.

Authors

Institutions

Publication Details

Journal
Cell Division
Published
2025-12-31
DOI
https://doi.org/10.1186/s13008-025-00175-9
Primary Topic
Autophagy in Disease and Therapy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

MiR-124-3p inhibits stomach adenocarcinoma progression by targeting AHR to induce autophagy

Shanling Xu, Xiangyun Li, Xinyi Liu, Qian Wan et al.
Cell Division
Autophagy in Disease and Therapy
article

MiR-124-3p inhibits stomach adenocarcinoma progression by targeting AHR to induce autophagy

Shanling Xu, Xiangyun Li, Xinyi Liu, Qian Wan, Siwei Wang, Wei Dong, Chuan Liu
article en

Abstract

These findings establish miR-124-3p as a key suppressor of STAD progression via AHR-mediated autophagy, underscoring its promise as both a diagnostic biomarker and a therapeutic candidate.

Cell DivisionVol. 21(1)
Wuhan University (CN), Sichuan Cancer Hospital (CN), Renmin Hospital of Wuhan University (CN)
Good health and well-being
Openalex Percentile: Top 28%
Autophagy in Disease and Therapy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.